Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Alliance Pharma ( (GB:APH) ) just unveiled an announcement.
Alliance Pharma PLC, a company involved in the pharmaceutical industry, is undergoing a recommended acquisition by Aegros Bidco Limited, which is indirectly owned by DBAY Affiliates and the ERES IV Fund. The acquisition will be implemented through a Court-sanctioned scheme of arrangement. The Court Meeting and General Meeting originally scheduled for 28 February 2025 have been adjourned to 13 March 2025 to allow further discussions with shareholders. The Alliance Directors continue to recommend the Cash Offer as fair and reasonable, while regulatory conditions have been met with foreign direct investment clearances from Italy and Ireland.
More about Alliance Pharma
YTD Price Performance: 32.46%
Average Trading Volume: 4,072,107
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £327.6M
See more data about APH stock on TipRanks’ Stock Analysis page.